Publication | Open Access

Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses

Tumor HeterogeneityMedicineGynecologyPathologyTp53 Mutation StatusTp53 ImmunohistochemistryCancer GenomicsCancer GeneticsOncologyOvarian Mucinous TumorsTumor BiologyOvarian Cancer